Virginia Tech finds possible biomarker for rare immunodeficiency condition

Virginia Tech researchers believe they've found a possible biomarker to help detect a rare genetic disease known as severe combined immunodeficiency, or SCID, which leaves patients needing to avoid all human contact and breathe filtered air in order to survive. As HealthCanal reported, a study comparing gut microbes in healthy mice with those that have a defective immune system found that the defective mice had more of a microbe known as Akkermansia muciniphila. But a bone marrow transplant helped those mice develop a more adaptive immune system. The same intestinal microbe can be found in humans. Further research is needed, but the team said their work represents a first step toward potentially addressing SCID, which is loosely related to HIV/AIDS and affects less than 0.1% of the human population. The idea is that a diagnostic biomarker could lead to quicker treatment and boost patients' survival chances. SCID patients are already treated with bone marrow transplants. The Virginia Tech team's work is published in detail in The ISME Journal. Story

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.